Skip to main content
. 2018 Jan 25;124(8):1660–1672. doi: 10.1002/cncr.31232

Figure 1.

Figure 1

Deaths due to chronic myeloid leukemia (CML) relative to the approval of tyrosine kinase inhibitors (TKIs). The number of new CML cases and the number of deaths due to CML for the years 1992 through 2013 are shown, with the approval of TKIs for the treatment of CML indicated. Reproduced from SEER Stat Fact Sheets: Chronic myeloid leukemia (CML). Statistics at a Glance. https://seer.cancer.gov/statfacts/html/cmyl.html. Accessed May 31, 2016 (available in the public domain).5